DRKS00005807
Recruiting
Not Applicable
Refractory Rheumatoid Arthritis - The reRA Study
Abteilung für RheumatologieMedizinische Universität Wien0 sites219 target enrollmentFebruary 28, 2014
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- M05
- Sponsor
- Abteilung für RheumatologieMedizinische Universität Wien
- Enrollment
- 219
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Rheumatoide arthritis:
- •Cases (refractory RA): high/ moderate disease activity despite \>4 DMARDs; Controls: achievement of remission/low disease activity within th first two DMARD courses.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Prospective cohort study of rheumatoid arthritis and Sjogren's syndrome (Prevention against the development of rheumatoid arthritis, collaboration with Kanazawa, Chiba and Nagasaki UniversityEarly arthritisJPRN-UMIN000014881agasaki University Hospital250
Recruiting
Not Applicable
Prospective cohort study of rheumatoid arthritis and Sjogren's syndrome (Prevention against the development of rheumatoid arthritis, through application of musculoskeletal ultrasonography and treatment for periodontal disease, collaboration with Kanazawa, Chiba and Nagasaki UniversityEarly arthritisJPRN-UMIN000014886agasaki University Hospital250
Active, not recruiting
Phase 1
REDO study: Research into the effects of lower doses rituximab in patients with rheumatoid arthritisEUCTR2016-002908-15-NLSint Maartenskliniek140
Completed
Not Applicable
Follow-up study of patients with rheumatoid arthritis who treated infliximab for 1 year and did not reach a clinical remission in RRRR StudyRheumatoid ArthritisJPRN-UMIN000007539niversity of Occupational and Environmental Health, Japan108
Suspended
Not Applicable
The RAINBOW study: Rheumatoid Arthritis ImplemeNtation of Biological dose Optimization in real WorldRheumatoid Arthritis (RA)NL-OMON22185This is an investigator-initiated study, funded by the Sint Maartenskliniek320